NCT05177107 - Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

January 30, 2025

Study Completion Date

May 30, 2025

Conditions

OsteomyelitisDiabetic Foot Osteomyelitis

Interventions

BIOLOGICAL

Bacteriophage Therapy

Bacteriophage therapy will be personalized for each patient dependent on phage susceptibility testing

OTHER

Placebo

Placebo (normal saline)

Trial Locations (15)

Foot and Ankle Specialists of the Mid-Atlantic, Salem

Salem VA, Salem

Infectious Disease Consultants od the Treasure Coast, Sebastian

Holy Cross Health, Fort Lauderdale

Henry Ford Health, Detroit

Podiatry 1st / Gateway Clinical Trials, O'Fallon

Foot & Ankle Center of Illinois, Springfield

Bio X Cell Research LLC, San Antonio

Futuro Clinical Trials, LLC, McAllen

Rocky Mountain VA, Aurora

Southern Arizona VA Health Care System, Tuscon

Harbor Hospital / UCLA, Torrance

NorthBay Healthcare, Fairfield

Holy Name Medical Center, Teaneck

CurAlta Foot and Ankle, Westwood